Clinicopathological significance of atypical glandular cells on Pap smear
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective To investigate the clinical significance of atypical glandular cells (AGC) by analyzing the prevalence and histologic outcomes of patients with AGC according to Pap smear. Methods The medical records of 83 patients who were diagnosed AGC on Pap tests at the Pusan National University Hospital outpatient department and health care center from January 1998 to March 2006 were reviewed. Results The prevalence of AGC was 55 of 54,160 (0.10%) and 28 of 54,160 (0.05%) for AGC-not otherwise specified (NOS) and neoplastic associated AGC, respectively. The histopathologic results of the AGC-NOS group (n=55) were as follows: low-grade squamous intraepithelial lesion, 7 (12.7%); high-grade squamous intraepithelial lesion, 4 (7.2%); adenocarcinoma of cervix, 3 (5.4%); endometrial carcinoma, 2 (3.6%); and other malignancies including 2 ovarian cancer cases and 1 breast cancer case, 3 (5.4%). The histopathologic results for the AGC-associated neoplastic group (n=28) were as follows: low-grade squamous intraepithelial lesion, 1 (3.5%); high-grade squamous intraepithelial lesion, 3 (10.7%); adenocarcinoma of cervix, 5 (17.8%); endometrial carcinoma, 4 (4.8%); and additional malignancies including 3 stomach cancer cases, 2 ovarian cancer cases, and 2 breast cancer cases; 7 (25%). Conclusion AGCs may represent a variety of benign and malignant lesions. AGC-associated neoplastic findings may be related to gynecological or extrauterine malignancies. Thus, when AGCs, especially neoplastic AGCs, are encountered, it is best to evaluate the cervix not only for typical maladies, but also for gynecological and non-gynecological malignancies.
Abstract
Objective To investigate the clinical significance of atypical glandular cells (AGC) by analyzing the prevalence and histologic outcomes of patients with AGC according to Pap smear. Methods The medical records of 83 patients who were diagnosed AGC on Pap tests at the Pusan National University Hospital outpatient department and health care center from January 1998 to March 2006 were reviewed. Results The prevalence of AGC was 55 of 54,160 (0.10%) and 28 of 54,160 (0.05%) for AGC-not otherwise specified (NOS) and neoplastic associated AGC, respectively. The histopathologic results of the AGC-NOS group (n=55) were as follows: low-grade squamous intraepithelial lesion, 7 (12.7%); high-grade squamous intraepithelial lesion, 4 (7.2%); adenocarcinoma of cervix, 3 (5.4%); endometrial carcinoma, 2 (3.6%); and other malignancies including 2 ovarian cancer cases and 1 breast cancer case, 3 (5.4%). The histopathologic results for the AGC-associated neoplastic group (n=28) were as follows: low-grade squamous intraepithelial lesion, 1 (3.5%); high-grade squamous intraepithelial lesion, 3 (10.7%); adenocarcinoma of cervix, 5 (17.8%); endometrial carcinoma, 4 (4.8%); and additional malignancies including 3 stomach cancer cases, 2 ovarian cancer cases, and 2 breast cancer cases; 7 (25%). Conclusion AGCs may represent a variety of benign and malignant lesions. AGC-associated neoplastic findings may be related to gynecological or extrauterine malignancies. Thus, when AGCs, especially neoplastic AGCs, are encountered, it is best to evaluate the cervix not only for typical maladies, but also for gynecological and non-gynecological malignancies.
참고문헌 (20)
- Annual report of Korean central cancer registry (2002.1-2002.12), "Central cancer registry center in Korea", Korean Central Cancer Registry Center, Ministry of Health & Welfare, ~ (2003)
- 부인종양위원회, "한국 부인암 등록 사업 조사 보고서 (2004.1.1 - 2004.12.31)", Obstetrics & Gynecology Science, 50(1), pp.28~78 (2007), 대한산부인과학회
- Papanicolaou GN, "The diagnostic value of vaginal smears in carcinoma of the uterus", Am J Obstet Gynecol, 42, pp.193~206 (1941)
- Fremont-Smith M, "Comparison of the SurePath liquid-based Papanicolaou smear with the conventional Papanicolaou smear in a multisite direct-to-vial study", Cancer, 102, pp.269~279 (2004)
- Wright TC Jr, "Cervical cancer screening in the 21st century: is it time to retire the PAP smear?", Clin Obstet Gynecol, 50, pp.313~323 (2007)
- Collins LC, "Qualifiers of atypical squamous cells of undetermined significance help in patient management", Mod Pathol, 9, pp.677~681 (1996)
- "The Bethesda System for reporting cervical", vaginal cytologic diagnoses: revised after the second National Cancer Institute Workshop, April 29-30, 1991, 1993, pp.37, 115~124
- Solomon D, "The 2001 Bethesda System: terminology for reporting results of cervical cytology", JAMA, 287, pp.2114~2119 (2002)
- Wright TC, "Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities", Obstet Gynecol, 85, pp.202~210 (1995)
- Lonky NM, "Low-grade Papanicolaou smears and the Bethesda system : a prospective cytohistopathologic analysis", Obstet Gynecol, 85, pp.716~720 (1995)
- Kinney WK, "Where’s the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses", Obstet Gynecol, 91, pp.973~976 (1998)
- Cox JT, "Management of atypical squamous cells of undetermined significance and low-grade squamous intra-epithelial lesion by human papillomavirus testing", Best Pract Res Clin Obstet Gynaecol, 15, pp.715~741 (2001)
- Melnikow J, "Natural history of cervical squamous intraepithelial lesions : a meta-analysis", Obstet Gynecol, 92, pp.727~735 (1998)
- Meath AJ, "Atypical glandular cells of undetermined significance. Review of final histologic diagnoses", J Reprod Med, 47, pp.249~252 (2002)
- Bulk S, "Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands", Br J Cancer, 94, pp.171~175 (2006)
- Chhieng DC, "Clinical implications of atypical glandular cells of undetermined significance, favor endometrial origin", Cancer, 93, pp.351~356 (2001)
- Seok WI, "Clinical analysis of atypical glandular cells of undetermined significance (AGUS) on Pap smear according to menopausal status", Korean J Obstet Gynecol, 45, pp.967~971 (2002)
- Schnatz PF, "Clinical significance of atypical glandular cells on cervical cytology", Obstet Gynecol, 107, pp.701~708 (2006)
- Schnatz PF, "Atypical glandular cells on cervical cytology and breast disease: what is the association?", J Low Genit Tract Dis, 15, pp.189~194 (2011)
- Sharpless KE, "Lack of adherence to practice guidelines for women with atypical glandular cells on cervical cytology", Obstet Gynecol, 105, pp.501~506 (2005)